Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (232)	7/27/1998 3:00:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 4974

OFF TOPIC capital market open for hypesters, hucksters, big money "smart" folks, jerks, and even crooks, to make money, to be gurus. So maybe it is better for biotech companies to avoid the dumb money of the equity markets and the volatility that this creates. To what extent do you think that some smart companies avoid all of that and simply do private placements? (The most recent message on the ntii thread suggested that might happen with that one... www2.techstocks.com I have shares in ntii and would like to hear opinions from the members of this thread what they think of biotech and drug discovery companies who resort to private placements to fund their operations. Is it generally regarded as bad short term because it dilutes the shares outstanding, but good longer term because it keeps the company afloat until success? (I mentioned ntii--but don't anybody rush to look at the chart and assume somebody is buying and get excited--it traded actively two days last week, but the stock is essentially dead until news).